Tags

Type your tag names separated by a space and hit enter

Cell-Cell Fusion Assays to Study Henipavirus Entry and Evaluate Therapeutics.
Methods Mol Biol. 2023; 2682:59-69.MM

Abstract

Henipaviruses include the deadly zoonotic Nipah (NiV) and Hendra (HeV) paramyxoviruses, which have caused recurring outbreaks in human populations. A hallmark of henipavirus infection is the induction of cell-cell fusion (syncytia), caused by the expression of the attachment (G) and fusion (F) glycoproteins on the surface of infected cells. The interactions of G and F with each other and with receptors on cellular plasma membranes drive both viral entry and syncytia formation and are thus of great interest. While F shares structural and functional homologies with class I fusion proteins of other viruses such as influenza and human immunodeficiency viruses, the intricate interactions between the G and F glycoproteins allow for unique approaches to studying the class I membrane fusion process. This allows us to study cell-cell fusion and viral entry kinetics for BSL-4 pathogens such as NiV and HeV under BSL-2 conditions using recombinant DNA techniques. Here, we present approaches to studying henipavirus-induced membrane fusion for currently identified and emerging henipaviruses, including more traditional syncytia counting-based cell-cell fusion assay and a new heterologous fluorescent dye exchange cell-cell fusion assay.

Authors+Show Affiliations

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. ha363@cornell.edu.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

37610573

Citation

Monreal, I Abrrey, and Hector C. Aguilar. "Cell-Cell Fusion Assays to Study Henipavirus Entry and Evaluate Therapeutics." Methods in Molecular Biology (Clifton, N.J.), vol. 2682, 2023, pp. 59-69.
Monreal IA, Aguilar HC. Cell-Cell Fusion Assays to Study Henipavirus Entry and Evaluate Therapeutics. Methods Mol Biol. 2023;2682:59-69.
Monreal, I. A., & Aguilar, H. C. (2023). Cell-Cell Fusion Assays to Study Henipavirus Entry and Evaluate Therapeutics. Methods in Molecular Biology (Clifton, N.J.), 2682, 59-69. https://doi.org/10.1007/978-1-0716-3283-3_4
Monreal IA, Aguilar HC. Cell-Cell Fusion Assays to Study Henipavirus Entry and Evaluate Therapeutics. Methods Mol Biol. 2023;2682:59-69. PubMed PMID: 37610573.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cell-Cell Fusion Assays to Study Henipavirus Entry and Evaluate Therapeutics. AU - Monreal,I Abrrey, AU - Aguilar,Hector C, PY - 2023/8/24/medline PY - 2023/8/23/pubmed PY - 2023/8/23/entrez KW - Class I fusion protein KW - Entry kinetics KW - F-triggering KW - Henipavirus KW - Heptad repeat KW - Luciferase reporter assay KW - Membrane fusion KW - Split GFP KW - Split protein KW - Syncytia SP - 59 EP - 69 JF - Methods in molecular biology (Clifton, N.J.) JO - Methods Mol Biol VL - 2682 N2 - Henipaviruses include the deadly zoonotic Nipah (NiV) and Hendra (HeV) paramyxoviruses, which have caused recurring outbreaks in human populations. A hallmark of henipavirus infection is the induction of cell-cell fusion (syncytia), caused by the expression of the attachment (G) and fusion (F) glycoproteins on the surface of infected cells. The interactions of G and F with each other and with receptors on cellular plasma membranes drive both viral entry and syncytia formation and are thus of great interest. While F shares structural and functional homologies with class I fusion proteins of other viruses such as influenza and human immunodeficiency viruses, the intricate interactions between the G and F glycoproteins allow for unique approaches to studying the class I membrane fusion process. This allows us to study cell-cell fusion and viral entry kinetics for BSL-4 pathogens such as NiV and HeV under BSL-2 conditions using recombinant DNA techniques. Here, we present approaches to studying henipavirus-induced membrane fusion for currently identified and emerging henipaviruses, including more traditional syncytia counting-based cell-cell fusion assay and a new heterologous fluorescent dye exchange cell-cell fusion assay. SN - 1940-6029 UR - https://www.unboundmedicine.com/medline/citation/37610573/Cell_Cell_Fusion_Assays_to_Study_Henipavirus_Entry_and_Evaluate_Therapeutics_ DB - PRIME DP - Unbound Medicine ER -